Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation, ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide not only reduce body weight in obesity but are also approved to treat other ...

Studies have shown that bariatric surgery can raise the risk of alcohol use disorder (AUD) and other addictive behaviors, a phenomenon often described as "addiction transfer." Treatment with ...

We aimed to investigate whether the reduced incretin effect observed in patients with type 2 diabetes is a primary event in the pathogenesis of type 2 diabetes or a consequence of the diabetic state.

Incretin-based therapies have advanced treatment of type 2 diabetes but have been linked to pancreatitis and pancreatic cancer in some patients. Conflicting evidences for and against this suspicious ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Biologically active GLP-1 7–36 amide is derived from proglucagon through post-translational processing. Proglucagon is generated throughout the small and large intestines in specialized intestinal ...